Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 ...
LEXINGTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat
Source: eagletribune.com